Study S002423

Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07810998
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 60
Start: 2026-09-10
Primary completion: 2027-04-30
Lead sponsor: Tanta University
Conditions: Poly Cystic Ovary Syndrome
Interventions: DRUG:Metformin; DRUG:Dapagliflozin (10mg Tab)
Results posted: FALSE

Registered primary outcomes

Fertility parameters- Luteinizing hormone [3-months]
Fertility parameters- Follicle stimulating hormone [3-months]
Fertility parameters-Total testosterone [3-months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.